▶ 調査レポート

オメガ3PUFAのアジア市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:Asia-Pacific Omega-3 PUFA Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。オメガ3PUFAのアジア市場:成長・動向・市場規模予測(2020-2025) / Asia-Pacific Omega-3 PUFA Market - Growth, Trends, and Forecast (2020 - 2025) / D0-MOR-AP1505資料のイメージです。• レポートコード:D0-MOR-AP1505
• 出版社/出版日:Mordor Intelligence / 2020年4月
• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:食品&飲料
• 販売価格(消費税別)
  Single User¥412,500 (USD3,750)▷ お問い合わせ
  Team User¥467,500 (USD4,250)▷ お問い合わせ
  Corporate License¥770,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、オメガ3PUFAのアジア市場について調査・分析した資料で、オメガ3PUFAの市場概要、動向、セグメント別市場規模、競争状況、企業情報、市場機会分析などで構成されています。

The Asia-Pacific Omega-3 PUFA Market is projected to grow at a CAGR of 8.2% during the forecast period.
– Rising disposable income in developing regions, such as the Asia Pacific is also one of the major reasons for the increase in spending on any food or supplement, which is positioned as healthy including omega-3 supplements.
– Manufacturers and suppliers involved actively in the supply chain of omega-3 in the Asia-Pacific region are making strategic efforts to ensure a gradual flow of information regarding the health benefits associated with omega-3 enriched diets, which has largely and positively affected the sales of omega-3 ingredients in the developing regions.

Key Market Trends

Increased Application in Dietary Supplements

Consumers are understanding the importance of incorporating supplements in their
regular diets. Omega-3 containing dietary supplements are proving to be a major attraction for almost every manufacturer, owing to their assistance in maintaining bone health, heart health and preventing hypertension, breast, prostate, and colon cancer, and even skin and eye-related disorders in both the geriatric as well as younger population segments. Healthcare professionals and physicians are also recommending omega-3 dietary supplements to their patients. This can be attributed to the robust growth of the omega-3 product market over the forecast period

China Holds the Maximum Share in Market

China is the largest market owing to the strong manufacturing base, increasing middle-class population, disposable income, and health awareness are fueling the consumption of EPA and DHA ingredients in China. The high birth rate and the recent abolition of the one-child policy in China are expected to fuel the demands for DHA-based ingredients for infant nutritional formulae. Infant formulae followed by dietary supplements are two major application areas in the Chinese EPA and DHA market. The dietary supplements sector in the China marketplace is expected to emerge as a lucrative application sector for EPA and DHA ingredients amid an increase in discretionary spending.

Competitive Landscape

The Asia-Pacific Omega-3 PUFA Market is consolidated and major companies hold maximum share in the market. Emphasis is given on the merger, expansion, acquisition, and partnership of the companies along with new product development as strategic approaches adopted by the leading companies to boost their brand presence among consumers. The key players in the market are BASF SE, Corbion N.V, and Koninklijke DSM N.V. among others.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY
3.1 Market Overview

4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Docosahexaenoic Acid (DHA)
5.1.2 Eicosapentaenoic Acid (EPA)
5.1.3 Alpha-Linolenic Acid (ALA)
5.1.4 Others
5.2 By Application
5.2.1 Food and Beverages
5.2.1.1 Functional Food and Beverages
5.2.1.2 Infant Nutrition
5.2.2 Dietary Supplements
5.2.3 Pharmaceuticals
5.2.4 Animal Nutrition
5.3 Geography
5.3.1 Asia Pacific
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 Rest of Asia Pacific

6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 BASF SE
6.4.2 Corbion N.V
6.4.3 Koninklijke DSM N.V.
6.4.4 Croda International Plc
6.4.5 KD Pharma Group
6.4.6 Clover Corporation Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS